[EN] TRICYCLIC DELTA OPIOID MODULATORS<br/>[FR] MODULATEURS DU RECEPTEUR OPIOIDE DOLLAR G(D) TRICYCLIQUES
申请人:JANSSEN PHARMACEUTICA NV
公开号:WO2005003131A1
公开(公告)日:2005-01-13
The invention is directed to delta opioid receptor modulators. More specifically, the invention relates to tricyclic δ-opioid modulators. Pharmaceutical and veterinary compositions and methods of treating mild to severe pain and various diseases using compounds of the invention are also described.
The invention is directed to delta opioid receptor modulators. More specifically, the invention relates to tricyclic δ-opioid modulators. Pharmaceutical and veterinary compositions and methods of treating mild to severe pain and various diseases using compounds of the invention are also described.
The invention is directed to delta opioid receptor modulators. More specifically, the invention relates to tricyclic δ-opioid modulators. Pharmaceutical and veterinary compositions and methods of treating mild to severe pain and various diseases using compounds of the invention are also described.
Thiozanthene derivatives as delta-opioid modulators
申请人:Janseen Pharmacautica NV
公开号:US07982042B2
公开(公告)日:2011-07-19
The invention is directed to delta opioid receptor modulators. More specifically, the invention relates to tricyclic δ-opioid modulators. Pharmaceutical and veterinary compositions and methods of treating mild to severe pain and various diseases using compounds of the invention are also described.
Tricyclic-bridged piperidinylidene derivatives as 8-opioid modulators
申请人:Janssen Pharmaceutica N.V.
公开号:US07589103B2
公开(公告)日:2009-09-15
Disclosed are compounds, compositions and methods for treating various diseases and conditions, including pain. Such compounds are represented by Formula I as follows:
wherein A, Z, Y, R1-R5 are defined herein.